EBITDA at other companies
Other financials
Where this comes from
Calculated from Lifecore Biomedical, Inc.’s reported figures.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s EBITDA?
- Lifecore Biomedical, Inc. (LFCR) reported EBITDA of -$2.36M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s EBITDA changed year-over-year?
- Lifecore Biomedical, Inc.'s EBITDA decreased by 395.3% year-over-year, from $800K to -$2.36M.
- What is the long-term trend for Lifecore Biomedical, Inc.'s EBITDA?
- Over 2 years (2022 to 2025), Lifecore Biomedical, Inc.'s EBITDA has grown at a 70.7% compound annual growth rate (CAGR), from $5.38M to -$15.66M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.